Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab

Mayo Clinic Proceedings

Volumn 76, Issue 9, 2001, Pages 890-896

  Cote, Annie V ^a   Berger, Peter B ^a   Holmes, David R ^a   Scott, Christopher G ^a   Bell, Malcolm R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; HEPARIN; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; VASCULAR DISEASE;

EID: 0034846720     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.9.890     Document Type: Article

References (16)

1. Current complications of diagnostic and therapeutic cardiac catheterization
2. Peripheral vascular complications of coronary angioplasty
3. Post-catheterization vascular complications associated with percutaneous transluminal coronary angioplasty
4. Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques
5. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)
6. Predictors of groin complications after balloon and new-device coronary intervention
7. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
8. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
9. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
10. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
11. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention
12. Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial
13. Thrombolysis in Myocardial Infarction (TIMI) trial - Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
14. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction
15. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty
16. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomised, placebo-controlled trial